Company: HCTI
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076686
Chunk: 108

Company: Healthcare Triangle, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 108
---
, and capital
resources, and all other non-historical statements in this discussion are forward-looking statements and are based on the beliefs of our
management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially
from those discussed in or implied by forward looking statements as a result of various factors, including those discussed below and elsewhere
in this report, and in the sections entitled “Special Note Regarding Forward-Looking Statements” and “Risk Factors”
contained in the Company’s final prospectus for its initial public offering filed with the Securities and Exchange Commission (“SEC”).

Overview 

Healthcare Triangle, Inc. (the “Company”)
is a leading healthcare information technology company focused on advancing innovative, industry-transforming solutions in the areas of
cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry.

The Company was formed on October 29, 2019, as
a Nevada corporation and then converted into a Delaware corporation on April 24, 2020, to provide IT and data services to the Healthcare
and Life Sciences (“HCLS”) industry. The business commenced on January 1, 2020, after SecureKloud Technologies Inc, transferred
its Life Sciences business to us. As of June 30, 2025, we had a total of 44 full time employees and 34 sub-contractors, including 18 certified
cloud engineers, 6 Epic Certified EHR experts, 8 MEDITECH Certified EHR experts and 2 Admin sub-contractors. Many of the senior management
team and the members of our board of directors hold advanced degrees and some are leading experts in the field of technology, investment
banking and public markets.

During the quarter ended June 30, 2025, the Company
generated revenues of approximately $3.5 million compared to revenue of $2.9 million for the quarter ended June 30, 2024 which represents
an increase of $0.6 million or 21% compared to the previous year.

Subsequent to the quarter ended June 30, 2025,
the Company effected a [1-for 249] reverse split of its issued and outstanding common stock on August 01, 2025. The reverse split reduced
the number of issued and outstanding shares of common stock in proportion to the split ratio, without changing the total authorized shares
or the par value per share.

Our approach leverages our proprietary technology
platforms,